Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Roche tries science in China's fight against fat

Article Abstract:

Roche Holding AG is now marketing the weight-loss drug Xenical through Chinese hospital clinics. The Swiss pharmaceutical company is emphasizing Xenical's scientific aspects to distinguish it from scam drugs and traditional remedies. Obesity in China is increasing as consumers are spending more on food but are not following nutrition and exercise guidelines.

Author: Chang, Leslie
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 2001
Marketing procedures, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Appetite Suppressants, Geographic, Channels of Distribution, Weight Control Centers, Diet and Weight Reducing Centers, Miscellaneous personal services, not elsewhere classified, Health aspects, Pharmaceutical industry, Marketing, Appetite depressants, Roche Holding Ltd., Reducing clinics, Weight loss industry, Diet industry, Xenical (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


IDG, News Corp. merge sites

Article Abstract:

International Data Group and News Corp. are to combine their Chinese Web sites, Yesky.com and ChinaByte.com, respectively. The merger reflects the consolidation trend that is taking place in China's Internet sector.

Author: Chang, Leslie
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 2001
Acquisitions & mergers, On-Line Information Services, Videotex & Teletext, Telegraph & other communications, Mergers, acquisitions and divestments, Online services, Internet services, The News Corporation Ltd., NWS, International Data Group Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Protests against NATO, U.S. have limited impact on tourism in China

Article Abstract:

The demonstrations in major Chinese cities over the bombing of the Chinese Embassy in Belgrade, Yugoslavia, by the North Atlantic Treaty Organization had a dramatic, albeit brief, impact on the country's tourism industry. Bookings declined sharply as the US and the UK advised travelers against going to China, but quickly returned to normal as the protests ended. Hotels and airlines experienced a drop in occupancy and passenger rates in the days following the protest, such as the Holiday Inn Lido in Beijing, which reported a decrease in room occupancy and banquet-room reservations and Dragon Airlines, which reported about 400 cancelled bookings.

Author: Chang, Leslie
Publisher: Dow Jones & Company, Inc.
Publication Name: The Asian Wall Street Journal Weekly
Subject: Business, international
ISSN: 0191-0132
Year: 1999
Sales & consumption, Scheduled Air Transportation, Intnl & Territorial Air Service, Hotels & Motels, Hotels (except Casino Hotels) and Motels, Tourist Travel, Economic aspects, International aspects, Airlines, Travel industry, Hotels and motels, Tourism, Demonstrations

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: China
Similar abstracts:
  • Abstracts: Tension with U.S. spurs threats by Web-site hackers in China. Asian technology
  • Abstracts: GLG Partners two-stepping to U.S. listing: hedge-fund manager seeks to raise capital and profile via NYSE. Lafarge relaunches convertible bond issue
  • Abstracts: Tsingtao thirsts for top ranks; expanding brewer guzzles companies having a tough time in China. From black sheep to broker's pet: PetroChina looks good
  • Abstracts: Fortis, shares tumbling, needs an activist to save it from itself. Fortis net gains 19% despite slowdown
  • Abstracts: Deutsche Post's net is expected to decline on higher tax charges. Deutsche Post gains in choppy first day
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.